FIELD: biotechnologies.
SUBSTANCE: invention refers to crystal forms 1 and 2 of anhydrous (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzil)phenyl)-6-(methylthio)tetrahydro-2n-pyran-3,4,5-triol, as well as to methods of their application for treating different illnesses and diseases, mainly diabetes.
EFFECT: reduction of glucose in blood, increase of glucose egestion with patient's urina and recovery of insulin sensitivity.
20 cl, 4 dwg, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS COMPRISING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2 AND METHODS OF USING THEREOF | 2012 |
|
RU2669921C2 |
| METHOD FOR PRODUCING DEPHENYLMETHANE DERIVATIVE | 2017 |
|
RU2797392C2 |
| METHOD OF PRODUCING DEPHENYLMETHANE DERIVATIVE | 2023 |
|
RU2814846C1 |
| C-GLYCOSIDE DERIVATIVES CONTAINING A CONDENSED PHENYL RING, OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, A METHOD OF PRODUCING SUCH AND A PHARMACEUTICAL COMPOSITION CONTAINING SUCH | 2017 |
|
RU2739024C2 |
| METHOD OF OBTAINING SGLT2 BENZYLENBENZOLE INHIBITORS | 2013 |
|
RU2625795C2 |
| BENZYL DERIVATIVES OF GLYCOSIDES AND METHODS OF THEIR APPLICATION | 2008 |
|
RU2492175C2 |
| SECONDARY MANNOSIS FOR BACTERIAL INFECTIONS TREATMENT | 2013 |
|
RU2667060C2 |
| CRYSTALLINE FORM OF BENZYL-BENZENE SGLT INHIBITOR | 2011 |
|
RU2569491C2 |
| CRYSTALLINE FORMS OF COMPLEXES USEFUL AS SGLT2 INHIBITORS, AND METHODS OF THEIR OBTAINING | 2014 |
|
RU2641905C2 |
| BENZYLPHENYLCYCLOHEXANE DERIVATIVES AND METHODS OF THEREOF APPLICATION | 2008 |
|
RU2505521C2 |
